Dostarlimab
Product Specifications
CAS Number
2022215-59-2
Target
PD-1/PD-L1
Related Pathways
Cell Cycle/Checkpoint, Apoptosis, Immunology/Inflammation
Purity
0.9892
Bioactivity
Dostarlimab (TSR-042) is a programmed cell death protein 1 (PD-1) receptor immune checkpoint inhibitor that blocks interactions with PD-L1 and PD-L2, used in the study of endometrial cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1212270-01 0.02 mg (E-Coli)
Recombinant Mycoplasma arthritidis Probable transcriptional regulatory protein MARTH_orf271 (MARTH_orf271)
Sign In for Pricing
View Details 
MBS1212270-02 0.1 mg (E-Coli)
Recombinant Mycoplasma arthritidis Probable transcriptional regulatory protein MARTH_orf271 (MARTH_orf271)
Sign In for Pricing
View Details MBS1212270-03 0.02 mg (Yeast)
Recombinant Mycoplasma arthritidis Probable transcriptional regulatory protein MARTH_orf271 (MARTH_orf271)
Sign In for Pricing
View Details MBS1212270-04 0.1 mg (Yeast)
Recombinant Mycoplasma arthritidis Probable transcriptional regulatory protein MARTH_orf271 (MARTH_orf271)
Sign In for Pricing
View Details MBS1212270-05 0.02 mg (Baculovirus)
Recombinant Mycoplasma arthritidis Probable transcriptional regulatory protein MARTH_orf271 (MARTH_orf271)
Sign In for Pricing
View Details